Schedule 13D ownership disclosure
Ensysce Biosciences, Inc.
Security class unavailable · CUSIP: 293602108
Event date: 2021-06-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,601,790
- Percent of class
- 9.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-21-016636
- Form type
- SC 13D
- Filer
- Ensysce Biosciences, Inc.
- CIK
- CIK 1716947
- Filed
- Jul 12, 2021
- Reporting period
- Jun 30, 2021
- Description
- Schedule 13D beneficial ownership